Skip to main content

Slow Acting Antirheumatics

  • Chapter
  • 120 Accesses

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 85))

Abstract

Rheumatoid arthritis (RA) is a chronic disease that produces systemic symptoms and a variety of extra-articular manifestations as well as inflammation of the joints with the capacity to cause damage to articular cartilage and erosion of periarticular bone. Since the etiology of the disease is unknown, therapy is not directed toward cure, but rather toward suppression of one or other aspects of the inflammatory process, in the hope of ameliorating local and systemic symptoms, and also preventing joint destruction.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adam M, Kuhn K (1968) Investigations on the reaction of metals with collagen in vivo. I. Comparison of the reaction of gold thiosulfate with collagen in vivo and in vitro. Eur J Biochem 3:407-410

    Article  PubMed  CAS  Google Scholar 

  • Amor B, Mery C, Degery A (1980) Tiopronine. New antirheumatic slow acting drug in rheumatoid arthritis. Rev Rheum 47:157-162

    CAS  Google Scholar 

  • Beutler B, Cerami A (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320:584-588

    Article  PubMed  CAS  Google Scholar 

  • Bluestone R, Goldberg LS (1973) Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis 32:50-52

    Article  PubMed  CAS  Google Scholar 

  • Burge JJ, Fearon DT, Austen KF (1978) Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitro. J Immunol 120:1626-1630

    Google Scholar 

  • Chaffman M, Brodgen RN, Heel RC, Speight TM, Avery GS (1984) Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Drugs 27:378-424

    Article  PubMed  CAS  Google Scholar 

  • Cooperating Clinics of the American Rheumatism Association (1970) A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl J Med 283:883-889

    Article  Google Scholar 

  • Cuperus RA, Muijsers AO, Weyer R (1985) Antiarthritis drugs containing thiol groups scavenge hypochloride and inhibit its formation by myeloperoxidase from human leukocytes. Arthritis Rheum 28:1228-1233

    Article  PubMed  CAS  Google Scholar 

  • Currey HLF, Harris J, Masin RM, Woodland J, Beveridge T, Roberts CJ, Vere DW, Dixon AStJ, Owen Smith B (1974) Comparison of azathioprine, cyclophosphamide and gold in treatment of rheumatoid arthritis. Br Med J 3:763-766

    Article  PubMed  CAS  Google Scholar 

  • Degre M, Mellbye OJ, Clarke-Jenssen 0 (1983) Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders. Ann Rheum Dis 42:672-676 Dinarello CA (1984) Interleukin 1. Rev Infect Dis 1:51-95

    Google Scholar 

  • Duke O, Panayi GS, Janossy G, Poulter LW (1982) An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 49:22-30

    PubMed  CAS  Google Scholar 

  • Ennis RS, Granda JL, Posner AS (1968) Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases. Arthritis Rheum 11:756-764

    Article  PubMed  CAS  Google Scholar 

  • Ghadially FN, Lipsky PE, Yang-Stepphuhn SE, Lalonde J-MA (1982) The morphology and atomic composition of aurosomes produced by sodium aurothiomalate in human monocytes. Ann Pathol 2:117-125

    PubMed  CAS  Google Scholar 

  • Gottlieb NL (1982) Comparative pharmacokinetics of parenteral and oral gold compounds. J Rheum [Suppl] 8:99-109

    CAS  Google Scholar 

  • Hanly JG, Bresnihan B (1985) Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis. Ann Rheum Dis 44:299-301

    Article  PubMed  CAS  Google Scholar 

  • Ho PPK, Young AL, Southland GL (1978) Methyl ester of N-formyl-methionyl-leucylphenylalanine: chemotactic responses of human blood monocytes and inhibition of gold compounds. Arthritis Rheum 21:133-136

    Article  PubMed  CAS  Google Scholar 

  • Husby G, Williams RC Jr (1985) Immunohistochemical studies of interleukin-2 and y-interferon in rheumatoid arthritis. Arthritis Rheum 28:174-181

    Article  PubMed  CAS  Google Scholar 

  • Huskisson EC, Jaffe IA, Scott J, Dieppe PA (1980) 5-Thiopyridoxine in rheumatoid arthritis: clinical and experimental studies. Arthritis Rheum 23:106-110

    Article  PubMed  CAS  Google Scholar 

  • Iannuzzi L, Dawson N, Zein N, Kushner I (1983) Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 309:1023-1028

    Article  PubMed  CAS  Google Scholar 

  • Jessop JD, Vernon-Roberts B, Harris J (1973) Effects of gold salts and prednisolone on inflammatory cells. I. Phagocytic activity of macrophages and polymorphs in inflammatory exudates studied by a “skin-window” technique in rheumatoid and control patients. Ann Rheum Dis 32:294-300

    Article  PubMed  CAS  Google Scholar 

  • Karsh J, Klippel JH, Plotz PH, Decker JL, Wright DG, Flye MW (1981) Lymphapheresis in rheumatoid arthritis. A randomized trial. Arthritis Rheum 24:867-873

    Article  PubMed  CAS  Google Scholar 

  • Klareskog L, Forsum U, Wigren A, Wigzell H (1982) Relationship between HLA-DR expression cells and T lymphocytes of different subsets in rheumatoid synovial tissue. Scand J Immunol 15:501-507

    Article  Google Scholar 

  • Kotzin BL, Strober S, Engelman EG, Calin A, Hoppe RT, Kansas GS, Terrell CP, Kaplan HS (1981) Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 305:969-976

    Article  PubMed  CAS  Google Scholar 

  • Lipsky PE (1981) Modulation of lymphocyte function by copper and thiols. Agents Actions [Suppl] 8:95-102

    Google Scholar 

  • Lipsky PE (1983) Remission-inducing therapy in rheumatoid arthritis. Am J Med 74(4b):40-49

    Article  Google Scholar 

  • Lipsky PE (1984) Immunosuppression by D-penicillamine in vitro: inhibition of human T lymphocyte proliferation by copper or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes. J Clin Invest 73:56-65

    Article  Google Scholar 

  • Lipsky PE, Ziff M (1977) Inhibition of antigen and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest 59:455-466

    Article  PubMed  CAS  Google Scholar 

  • Lipsky PE, Ziff M (1978) The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol 120:1006-1013

    PubMed  CAS  Google Scholar 

  • Lipsky PE, Ziff M (1980) Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. J Clin Invest 65:1069-1976

    Article  PubMed  CAS  Google Scholar 

  • Littman BH, Schwartz P (1982) Gold inhibition of the production of the second complement component by lymphokine-stimulated human monocytes. Arthritis Rheum 25:288-296

    Article  PubMed  CAS  Google Scholar 

  • Lorber A, Pearson CM, Meredith WL, Gantz-Mandell LE (1964) Serum sulfhydryl determinations and significance in connective tissue diseases. Ann Intern Med 61:423-434

    PubMed  CAS  Google Scholar 

  • Lorber A, Simon T, Leeb J, Peter A, Wilcox S (1978) Chrysotherapy. Suppression of immunoglobulin synthesis. Arthritis Rheum 21:785-791

    Article  PubMed  CAS  Google Scholar 

  • Martin MFR, McKenna F, Bird HA, Surrall KE, Dixon J, Wright V (1984) Captopril: a new treatment for rheumatoid arthritis. Lancet 1:1325-1327

    Article  PubMed  CAS  Google Scholar 

  • Multicentre Trial Group (1973) Controlled trial of D(-)-penicillamine in severe rheumatoid arthritis. Lancet 1:275-280

    Article  Google Scholar 

  • Nechay BR (1980) Inhibition of adenosine thriphosphatases by gold. Arthritis Rheum 23:464-470

    Article  PubMed  CAS  Google Scholar 

  • Norris DA, Weston DL, Smas WM (1977) The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro. J Lab Clin Med 90:569-580

    PubMed  CAS  Google Scholar 

  • Olsen N, Ziff M, Jasin HE (1984) Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine J Rheumatol 11:17-21

    PubMed  CAS  Google Scholar 

  • Paulus HE, Machleder HI, Levine S, Yu DTY, MacDonald NS (1977) Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 20:1249-1262

    Article  PubMed  CAS  Google Scholar 

  • Research Subcommittee of the Empire Rheumatism Council (1960 a) Gold therapy in rheumatoid arthritis. Report of a multi-centre controlled trial. Ann Rheum Dis 19:95-119

    Article  Google Scholar 

  • Research Subcommittee of the Empire Rheumatism Council (1960 b) Gold therapy in rheumatoid arthritis. Final report of a multi-centre controlled trial. Ann Rheum Dis 20:315-334

    Article  Google Scholar 

  • Salmeron G, Lipsky PE (1982) Modulation of human immune responsiveness in vitro by auranofin. J Rheum [Suppl 8] 9:25-32

    Google Scholar 

  • Salmeron G, Lipsky PE (1983) Immunosuppressive potential of antimalarials. Am J Med 75(1A):19-24

    Article  PubMed  CAS  Google Scholar 

  • Scheinberg MA, Santos LMB, Finkelstein AE (1982) The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes. J Rheum 9:366-369

    PubMed  CAS  Google Scholar 

  • Schultz DR, Volanakis JE, Arnold PJ, Gottlieb NL, Sakai K, Stroud RM (1974) Inactivation of Cl in rheumatoid synovial fluid, purified Cl and Cl esterase by gold compounds. Clin Exp Immunol 17:395-406

    PubMed  CAS  Google Scholar 

  • Staite ND, Messner RP, Zoschke DC (1985) In vitro production and scavenging of hydrogen peroxide by D-penicillamine: relationship to copper availability. Arthritis Rheum 28:914-921

    Article  PubMed  CAS  Google Scholar 

  • Starkebaum G, Root RK (1985) D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation. J Immunol 134:3371-3378

    PubMed  CAS  Google Scholar 

  • Steven MM, Hunter JA, Murdoch RM, Cappell HA (1982) Does the order of second-line treatment of rheumatoid arthritis matter? Br Med J 284:79-81

    Article  CAS  Google Scholar 

  • Stone KJ, Mather SJ, Gibson PP (1975) Selective inhibition of prostaglandin biosynthesis by gold and phenylbutazone. Prostaglandins 10:241-251

    PubMed  CAS  Google Scholar 

  • Trentham DE, Belli JA, Anderson RJ, Buckley JA, Goetzl EJ, David JR, Austin KF (1981) Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Eng J Med 305:976-982

    Article  CAS  Google Scholar 

  • Ugai K, Ziff M, Lipsky PE (1979) Gold-induced changes in the morphology and functional capabilities of human monocytes. Arthritis Rheum 22:1352-1360

    Article  PubMed  CAS  Google Scholar 

  • Vernon-Roberts B (1979) Action of gold salts on the inflammatory response and inflammatory cell function. J Rheum [Suppl] 5:120-129

    CAS  Google Scholar 

  • Vernon-Roberts B, Jessop JD, Dore J (1973) Effects of gold salts and prednisone on inflammatory cells. II. Suppression of inflammation and phagocytosis in the rat. Ann Rheum Dis 32:301-307

    Article  PubMed  CAS  Google Scholar 

  • Vernon-Roberts B, Dore JL, Jessop JD, Henderson WJ (1976) Selective concentration and localization of gold in macrophages of synovial and other tissue during and after chrysotherapy in rheumatoid patients. Ann Rheum Dis 35:477-486

    Article  PubMed  CAS  Google Scholar 

  • Wallace DJ, Goldfinger D, Gatti R, Lowe C, Fan P, Bluestone R, Klinenberg JR (1979) Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Arthritis Rheum 22:703-710

    Article  PubMed  CAS  Google Scholar 

  • Wallis WJ, Simkin PA, Nelp WB (1985) Low synovial clearance of iodide provides evidence of hypoperfusion in chronic rheumatoid synovitis. Arthritis Rheum 28:1096-1104

    Article  PubMed  CAS  Google Scholar 

  • Walz DT, Dimartino JJ (1972) Effect of anti-arthritic drugs on sulfhydryl reactivity of rat serum. Proc Soc Exp Biol Med 140:263-268

    PubMed  CAS  Google Scholar 

  • Zvaifler NJ (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265-236

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lipsky, P.E. (1988). Slow Acting Antirheumatics. In: Bray, M.A., Morley, J. (eds) The Pharmacology of Lymphocytes. Handbook of Experimental Pharmacology, vol 85. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73217-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73217-1_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73219-5

  • Online ISBN: 978-3-642-73217-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics